These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3080694)

  • 21. [Treatment of amyotrophic lateral sclerosis with daily intrathecal TRH. A year's experience. Pilot study II].
    Patrignani J; Proaño J; Morales MD
    Neurologia; 1992 Jan; 7(1):4-9. PubMed ID: 1596403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: experience with an intrathecal drug delivery system.
    Munsat TL; Taft J; Jackson IM; Andres PL; Hollander D; Skerry L; Ordman M; Kasdon D; Finison L
    Neurology; 1992 May; 42(5):1049-53. PubMed ID: 1579228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRH-induced reflex changes in patients with ALS.
    Hawley RJ; Sirdofsky M; Kratz R
    Electromyogr Clin Neurophysiol; 1989; 29(7-8):465-7. PubMed ID: 2514091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin-releasing hormone in ALS. Are the results of clinical studies inconsistent?
    Brooke MH
    Ann N Y Acad Sci; 1989; 553():422-30. PubMed ID: 2497684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of thyroliberin treatment on the thyrotropin and prolactin levels in patients with amyotrophic lateral sclerosis].
    Klimek A; Szulc-Kuberska J; Stepień H
    Neurol Neurochir Pol; 1990; 24(1-2):31-6. PubMed ID: 2132051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration.
    Brooks BR; Kalin N; Beaulieu DA; Barksdale C; Sufit RL; Dills DG
    Neurol Res; 1988 Dec; 10(4):236-8. PubMed ID: 2907112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low doses of TRH in amyotrophic lateral sclerosis and in other neurological diseases.
    Congia S; Tronci S; Ledda M; Porcella A; Coppola G
    Ital J Neurol Sci; 1991 Apr; 12(2):193-8. PubMed ID: 1906441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Note on the use of TRH in amyotrophic lateral sclerosis].
    Serratrice G
    Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
    [No Abstract]   [Full Text] [Related]  

  • 31. TRH and amyotrophic lateral sclerosis.
    Griffiths EC
    Neurology; 1987 Jan; 37(1):175-6. PubMed ID: 3099228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trial of thyrotropin-releasing factor in amyotrophic lateral sclerosis].
    Serratrice G; Desnuelle C; Guelton C; Meyer-Dutour A; Richard P; Braguer D; Crevat A
    Presse Med; 1985 Feb; 14(8):487-8. PubMed ID: 3157152
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose TRH treatment of neuromuscular diseases: summary of mechanisms and critique of clinical studies. Summary of section IX.
    Engel WK
    Ann N Y Acad Sci; 1989; 553():462-72. PubMed ID: 2497686
    [No Abstract]   [Full Text] [Related]  

  • 34. Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study.
    Lindström LH; Gunne LM; Ost LG; Persson E
    Acta Psychiatr Scand; 1977 Jan; 55(1):74-80. PubMed ID: 402794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary effects of thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Braun SR; Sufit RL; Brooks BR
    Lancet; 1984 Sep; 2(8401):529-30. PubMed ID: 6147597
    [No Abstract]   [Full Text] [Related]  

  • 36. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline.
    Karlberg BE; Kjellman BF; Kågedal B
    Acta Psychiatr Scand; 1978 Nov; 58(5):389-400. PubMed ID: 102114
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind trial of intravenous thyrotrophin-releasing hormone in the treatment of reactive depression.
    Evans LE; Hunter P; Hall R; Johnston M; Roy VM
    Br J Psychiatry; 1975 Sep; 127():227-30. PubMed ID: 810198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New hormone therapy. Thyrotropin releasing hormone].
    Sobue I
    Nihon Rinsho; 1987 Nov; 45(11):2671-8. PubMed ID: 3127616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.